By Nina Kienle
Glanbia said it targets higher adjusted earnings per share in the midterm as it sharpens its focus on growth ambitions.
The Irish nutrition group on Wednesday said it targets adjusted earnings per share growth in the range of 7% to 11% on a constant currency basis between 2026 and 2028.
It also targets return on capital employed in the range of 10% to 13%, with a progressive dividend maintained, it added.
In the performance nutrition segment the company aims for annual organic revenue growth of 5% to 7%. It targets a 250 basis point progression in its total three-year earnings before interest, taxes, depreciation, and amortization margin from its 2025 reported base.
In health and nutrition, Glanbia targets annual organic revenue growth of between 4% an 6%, as well as an Ebitda margin range of 17% to 19%.
In dairy nutrition, an annual Ebitda range of around $150 million to $160 million is targeted.
"We are well-positioned to deliver on our ambition to drive growth and shareholder returns," Chief Executive Hugh McGuire said.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
November 19, 2025 03:11 ET (08:11 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.